The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials
Open accessAbstract
OBJECTIVE: To summarise the effect of primary prevention with lipid lowering drugs on coronary heart disease events, coronary heart disease mortality, and all cause mortality. DESIGN: Meta-analysis. IDENTIFICATION: Systematic search of the Medline database from January 1994 to June 1999 for English language studies examining drug treatment for lipid disorders (use of the MeSH terms "hyperlipidemia" and "anticholesteremic agents," keyword searches for individual drug names, and a search strategy for identifying randomised trials to capture relevant articles); identification of older studies through systematic reviews and hand search of bibliographies. INCLUSION CRITERIA: All randomised trials of at least one year's duration that examined drug treatment for patients with no known coronary heart disease, cerebrovascular disease, or peripheral vascular disease and that measured clinical end points, including all cause mortality, coronary heart disease mortality, and non-fatal myocardial infarctions. DATA EXTRACTION: Review of the articles and extracted relevant data by two authors separately, with disagreements resolved by consensus. RESULTS: Four studies met eligibility criteria. Drug treatment reduced the odds of a coronary heart disease event by 30% (summary odds ratio 0.70, 95% confidence interval 0.62 to 0.79) but not the odds of all cause mortality (0.94, 0.81 to 1.09). When statin drugs were considered alone, no substantial differences in results were found. CONCLUSIONS: Treatment with lipid lowering drugs lasting five to seven years reduces coronary heart disease events but not all cause mortality in people with no known cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
(1984) · JAMA · doi:10.1001/jama.251.3.365 · Cited by 643
Salonen, R., Nyyssönen, K., Porkkala, E., Rummukainen, J., Belder, R., Park, J.-S., & Salonen, J. T. (1995) · Circulation · doi:10.1161/01.cir.92.7.1758 · Cited by 540
HEBERT, P. R., GAZIANO, J. M., CHAN, K. S., & HENNEKENS, C. H. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199806000-00060 · Cited by 506
Cholesterol lowering and mortality: the importance of considering initial level of risk.
Smith, G. D., Song, F., & Sheldon, T. A. (1993) · BMJ · doi:10.1136/bmj.306.6889.1367 · Cited by 423
Bradford, R. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010067008 · Cited by 372
Elkeles, R. S., Diamond, J. R., Poulter, C., Dhanjil, S., Nicolaides, A. N., Mahmood, S., Richmond, W., Mather, H., Sharp, P., Feher, M. D., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.641 · Cited by 271
Mercuri, M., Bond, M. G., Sirtori, C. R., Veglia, F., Crepaldi, G., Saverio Feruglio, F., Descovich, G., Ricci, G., Rubba, P., Mancini, M., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00333-6 · Cited by 253
Caro, J., Klittich, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., & Shepherd, J. (1997) · BMJ · doi:10.1136/bmj.315.7122.1577 · Cited by 203
Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality
Dorr, A. E., Gundersen, K., Schneider, J. C., Spencer, T. W., & Martin, W. B. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90076-0 · Cited by 203
(1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90858-a · Cited by 182
Pharoah, P. D. P., & Hollingworth, W. (1996) · BMJ · doi:10.1136/bmj.312.7044.1443 · Cited by 168
Ramsay, L., Haq, I., Jackson, P., Yeo, W., Pickin, D., & Payne, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05516-x · Cited by 168
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.278.4.313 · Cited by 162
Athyros, V. G., Papageorgiou, A. A., Hatzikonstandinou, H. A., Didangelos, T., Carina, M., Kranitsas, D. F., & Kontopoulos, A. G. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00430-x · Cited by 157
Lipid Research Clinics Coronary Primary Prevention Trial Results
Virkkunen, M. (1985) · JAMA · doi:10.1001/jama.1985.03350290037018 · Cited by 136
A simple computer program for guiding management of cardiovascular risk factors and prescribing
Hingorani, A. D., & Vallance, P. J. (1999) · BMJ · doi:10.1136/bmj.318.7176.101 · Cited by 118
Eriksson, M., Hådell, K., Holme, I., Walldius, G., & Kjellström, T. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00294.x · Cited by 61
Use and Outcomes of a Cholesterol-Lowering Intervention for Rural Elderly Subjects
Ives, D. G., Kuller, L. H., & Traven, N. D. (1993) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30703-7 · Cited by 35
The Long-term Effects of Probucol on Serum Lipid Levels
McCaughan, D. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340120036010 · Cited by 27
Bredie, S. J. H. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(96)00015-0 · Cited by 22
Lansberg, P. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05523-y · Cited by 18
The Kyushu Lipid Intervention Study Group (1996) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.3.95 · Cited by 15
Efficacy of drug intervention for lipids in the prevention of coronary artery disease
Howes, L. G., & Simons, L. A. (1994) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1994.tb04445.x · Cited by 5
Cited by
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Law, M. R., Wald, N. J., & Rudnicka, A. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1423 · Cited by 1,720
Critchley, J. A., & Capewell, S. (2003) · JAMA · doi:10.1001/jama.290.1.86 · Cited by 1,089
Comparative quantification of health risks conceptual framework and methodological issues
Murray, C. J., Ezzati, M., Lopez, A. D., Rodgers, A., & Vander Hoorn, S. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-1 · Cited by 887
Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1147 · Cited by 506
Metadata
- Authors
- Pignone, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-10-21
- Volume
- 321
- Issue
- 7267
- Pages
- 983-986
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W1983625180
- Cited by
- 259
- References
- 31
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.